Editorial & Content Policy
How Aseptic Enclosures creates, reviews, fact-checks, and updates content on sterile compounding, USP 797, USP 800, cleanroom compliance, and aseptic processing equipment — and the standards we hold ourselves to for every pharmacist, compounding director, and facility manager who relies on this information.
Why this page exists: Aseptic Enclosures publishes content on topics — USP 797, USP 800, hazardous drug containment, sterile compounding — that directly affect patient safety and regulatory compliance. Our readers deserve to know exactly how that content is created, reviewed, updated, and corrected.
Our Mission & Content Purpose
Aseptic Enclosures publishes educational content to help pharmacists, compounding directors, sterile compounding technicians, facility managers, and biotech professionals make well-informed decisions about cleanroom environments, aseptic processing equipment, and pharmaceutical compliance.
Our content covers USP Chapter 797, USP Chapter 800, FDA guidance, ASHP practice standards, cleanroom environmental monitoring, pharmacy planning and design, hazardous drug containment, and isolator technology. The environments our readers design and manage have a direct impact on patient safety — which is why we hold the accuracy of every article to the highest standard.
Core commitment: Every article we publish must be accurate, evidence-based, practically useful, and transparent about the limits of the information provided. We do not publish content designed to mislead, exaggerate, or substitute for qualified regulatory, legal, or clinical counsel.
Who Creates Our Content
Content on asepticenclosures.com is written and reviewed by team members with direct, hands-on experience in cleanroom design, pharmacy compliance, aseptic processing equipment, and USP regulatory standards. Our project team has managed hundreds of USP 797 and USP 800 compliance projects across the United States.
- Authors have practical experience in sterile compounding environments, isolator design, mobile cleanroom construction, and compounding pharmacy compliance
- Technical articles covering USP 797 or USP 800 requirements are reviewed by subject matter experts prior to publication
- Our client base includes Johns Hopkins, NIH, AbbVie, Labcorp Drug Development, the U.S. Department of Veterans Affairs, Mayo Clinic, SSM Health, and Ascension Health
- Content addressing clinical pharmacy, hazardous drug handling, or patient safety implications is reviewed with extra care before publication
- Author credentials and relevant experience are maintained in author profile pages across the site
Our Editorial Standards
All content published on asepticenclosures.com — whether educational, product-focused, news-based, or event-related — is held to the following principles without exception:
- All regulatory references (USP chapters, FDA guidance, ASHP practice standards, CDC guidelines) are sourced from their primary, authoritative, and currently published versions
- Product capability claims are based on documented manufacturer specifications and real-world data — not marketing generalisations
- Educational content is clearly distinguishable from commercial or promotional product content
- We do not accept payment from third-party manufacturers to publish, feature, or positively review their products in editorial content
- Sponsored or co-produced content — including webinars and product guides developed with suppliers — is clearly identified as such
- Content related to hazardous drug handling, patient safety, or clinical practice is held to especially rigorous accuracy standards
Fact-Checking & Review Process
Before any technical or regulatory article is published, it undergoes an internal review to verify factual accuracy, regulatory alignment, and practical relevance for our pharmacy and cleanroom professional audience.
- Technical articles are reviewed by at least one team member with direct, relevant expertise in the subject area before publication
- Regulatory claims referencing USP 797 or USP 800 are verified against the current, official published version of those chapters — not secondary summaries or unverified sources
- Equipment specifications and capability claims are confirmed against current manufacturer data sheets
- Statistical data, research references, and third-party claims are traced to their primary source before inclusion
- Specific compliance thresholds, ISO classification levels, or containment standards are verified against the applicable primary standard before publication
Important: Content on asepticenclosures.com is educational guidance, not legal, regulatory, or clinical compliance advice. All compliance decisions should be verified with your own qualified regulatory counsel, state board of pharmacy, and relevant clinical or safety advisors.
USP 797, USP 800 & Regulatory Reference Policy
Aseptic Enclosures publishes significant content specifically addressing USP Chapter 797 (Pharmaceutical Compounding — Sterile Preparations) and USP Chapter 800 (Hazardous Drugs — Handling in Healthcare Settings). Given the compliance-critical nature of this content, we follow a specific and rigorous policy:
- USP chapter references reflect the currently enforceable version of those chapters at the time of writing and publication
- When USP standards are revised — as occurred with the significant 2023 revision to USP 797 — relevant articles are reviewed and updated as quickly as practicable
- Links to regulatory documents point to primary sources (USP.org, FDA.gov, ASHP.org, CDC.gov) wherever possible
- State-specific pharmacy board requirements vary significantly — where state variation is relevant, this is noted explicitly within the article
- We do not present federal standards as automatically applicable to all practice settings without noting that state board requirements may differ
- Readers are always directed to consult their state board of pharmacy and qualified legal counsel for site-specific compliance decisions
Content Update Policy
Pharmaceutical regulation evolves continuously. USP chapters are revised. FDA issues new guidance. State boards of pharmacy update their rules. We are committed to keeping published content accurate and current — and to flagging outdated content rather than allowing it to mislead readers.
- Articles referencing specific USP chapter requirements are reviewed whenever those chapters are officially revised or when enforcement guidance changes materially
- All published articles display the original publication date and the date of any subsequent material update, clearly visible at the top of each post
- When significant changes are made, the revision is noted at the top of the post with the update date and a description of what changed and why
- Minor corrections — typographical errors, broken links, formatting — may be made without a formal revision notation
- Equipment product pages are reviewed whenever represented manufacturers publish significant specification or certification updates
Product & Equipment Representation Policy
This website may feature products and equipment belonging to companies that Aseptic Enclosures officially represents in the United States. All products, brands, and equipment displayed or referenced on this platform — including aseptic isolators, mobile cleanrooms, particle counters, HEPA filtration systems, monitoring systems, and related pharmaceutical-grade supplies — are listed exclusively with the full knowledge and written consent of the respective companies involved. Before any product or brand is featured on this website, a formal representation agreement is established between Aseptic Enclosures and the concerned company. This contract outlines the terms and conditions governing how the company’s products and brand identity are presented, marketed, and communicated to the public through our platform. We are committed to ensuring that all product information published on this website is accurate, up-to-date, and aligned with the guidelines provided by the represented companies. Any updates, modifications, or removal of product listings are carried out in accordance with the terms of the representation contract and at the request of the concerned parties. Our team works closely with each represented company to maintain the integrity and accuracy of all published content, ensuring that it reflects the company’s official standards, brand values, and compliance requirements within the aseptic processing and sterile compounding industry.
Corrections Policy
We take full accountability for the accuracy of what we publish. If an error is identified — by our own team or reported by a reader — we address it promptly, transparently, and with a clear public record of what changed.
- Factual errors are corrected as quickly as possible following identification and independent verification
- Corrections are noted within the article with the correction date and a plain-language description of what changed
- We do not silently edit factual errors — for content touching on regulatory compliance or patient safety, transparency is non-negotiable
- Errors affecting USP compliance guidance, hazardous drug handling, or patient safety content are treated as highest priority
- Every reader-reported error is investigated before changes are made — we do not correct based solely on unverified assertions
To report an error: Email support@asepticenclosures.com or call 1.800.418.9289. Include the article title, the specific claim you believe is inaccurate, and your source. We will investigate and respond.
Commercial Disclosure
Aseptic Enclosures is both a manufacturer of cleanroom and aseptic processing equipment and a publisher of educational content about those same topics. We are fully transparent about this dual role.
- Educational content that also discusses our products is published by Aseptic Enclosures — the source is always clearly identified
- We aim to make educational content genuinely useful for readers regardless of whether they ultimately purchase equipment from us
- We do not accept payment from third-party equipment manufacturers to feature or positively review their products in editorial content
- Content developed in partnership with other organisations — such as our collaboration with Life Scientific, Inc. — is identified as collaborative or co-produced
- Aseptic Enclosures does not serve third-party advertising on this site and does not allow advertisers to influence editorial content
External Links Policy
We include external links in our content to direct readers to primary regulatory sources, manufacturer documentation, clinical practice standards, and reference material that adds genuine value.
- Linking to an external site does not constitute an endorsement of all content, products, or positions on that site
- We prioritise official, authoritative sources: USP.org, FDA.gov, ASHP.org, CDC.gov, state board of pharmacy websites, and peer-reviewed clinical publications
- External links are reviewed as part of our periodic content maintenance — broken or outdated links are updated or removed
- We do not accept payment from third parties to include outbound links in editorial content
- Where we reference or summarise external content, our representation is accurate and not misleading
Contact Us About This Policy
We welcome questions, feedback, and error reports about the content we publish. If you have concerns about any article, want to understand our editorial process, or wish to report a potential error, please reach out directly.
- Phone: 1.800.418.9289 — Mon–Fri, 8:00am to 5:00pm CT
- Email: support@asepticenclosures.com
- Contact form: asepticenclosures.com/contact
- Mail: Aseptic Enclosures · 3720 Hampton Ave., Ste. 204 · St. Louis, MO 63109
This Editorial Policy was last reviewed and updated in April 2026. Aseptic Enclosures reviews this document annually and updates it whenever our editorial processes or the regulatory landscape changes materially.
